The main NRAS-mutations affect the glutamine at the amino-acid position 61, in 80–90 % of NRAS-mutant melanomas, with mutations encoded as NRASQ61R, NRASQ61L, and NRASQ61K. This evidence concerns the gene NRAS and melanoma.